Allogeneic hematopoietic SCT for patients with autoimmune diseases
- 12 January 2009
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 44 (1), 27-33
- https://doi.org/10.1038/bmt.2008.424
Abstract
Allogeneic hematopoietic SCT (HSCT) has been used as treatment for single patients with autoimmune diseases (AD). To summarise currently available information, we analyzed all patients who underwent allogeneic HSCT for AD and who reported to the European Group for Blood and Marrow Transplantation (EBMT) database. Thirty-five patients receiving 38 allogeneic transplantations for various hematological and non-hematological AD were identified. Four patients had had an allogeneic HSCT for a conventional hematological indication in the past. Fifty-five per cent of the transplantation procedures led to a complete clinical response of the refractory AD and 23% to at least a partial response. The median duration of response at the last follow-up was 70.7 (15.2–130) months. Three patients relapsed at a median of 12.3 months after HSCT. Treatment-related mortality at 2 years was 22.1% (95% CI: 7.3–36.9%). Two deaths were caused by progression of AD. The probability of survival at 2 years was 70%. No single factor predicting the outcome could be identified. The retrospective nature of this study and the heterogeneous, partly incomplete data are its limitations. However, allogeneic HSCT can induce remission in patients suffering from refractory AD. These data provide the basis for carefully conducted prospective trials.Keywords
This publication has 19 references indexed in Scilit:
- Allogeneic Bone Marrow Transplantation in Models of Experimental Autoimmune Encephalomyelitis: Evidence for a Graft-versus-Autoimmunity EffectTransplantation and Cellular Therapy, 2007
- Hematopoietic Stem-Cell TransplantationNew England Journal of Medicine, 2006
- Hematopoietic stem cell transplantation prevents diabetes in NOD mice but does not contribute to significant islet cell regeneration once disease is establishedExperimental Hematology, 2005
- Treatment of severe autoimmune disease by stem-cell transplantationNature, 2005
- Coincidental autoimmune disease in patients transplanted for conventional indicationsBest Practice & Research Clinical Haematology, 2004
- Preclinical experimentsBest Practice & Research Clinical Haematology, 2004
- Haematopoetic stem cell transplantation for refractory autoimmune cytopeniaBritish Journal of Haematology, 2004
- Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myelomaBone Marrow Transplantation, 2003
- Treatment of autoimmune diseases by hematopoietic stem cell transplantationExperimental Hematology, 2001
- Progression of rheumatoid arthritis following bone marrow transplantation. A case report with a 13‐year followupArthritis & Rheumatism, 1996